TY - JOUR
T1 - Signal-transducing adaptor protein-2 controls the IgE-Mediated, mast cell-mediated anaphylactic responses
AU - Sekine, Yuichi
AU - Nishida, Keigo
AU - Yamasaki, Satoru
AU - Muromoto, Ryuta
AU - Kon, Shigeyuki
AU - Kashiwakura, Jun Ichi
AU - Saitoh, Kodai
AU - Togi, Sumihito
AU - Yoshimura, Akihiko
AU - Oritani, Kenji
AU - Matsuda, Tadashi
PY - 2014/4/15
Y1 - 2014/4/15
N2 - Signal-transducing adaptor protein-2 (STAP-2) is a recently identified adaptor protein that regulates immune and inflammatory responses through interactions with a variety of signaling and transcriptional molecules. In the current study, we clarified the physiological role of STAP-2 in mast cell function, a key mediator of IgE-associated allergic responses. STAP-2 is constitutively expressed in mast cells. STAP-2 deficiency in mast cells greatly enhances FcRI-mediated signals, resulting in the increased tyrosine phosphorylation of the phospholipase C-g isoform, calcium mobilization, and degranulation. Of importance, STAP-2-deficient mice challenged with DNP-BSA after passive sensitization with anti-DNP IgE show more severe rectal temperature decrease than do wild-type mice. STAP-2-deficient mice also show increased vascular permeability and more severe cutaneous anaphylaxis after DNP-BSA injection. These regulatory functions performed by STAP-2 indicate that there is an interaction between STAP-2 and FcRI. In addition, our previous data indicate that STAP-2 binds to the phospholipase C-g isoform and IkB kinase-b. Therefore, our data described in this article strongly suggest that manipulation of STAP-2 expression in mast cells may control the pathogenesis of allergic diseases and have the potential for treating patients with allergy.
AB - Signal-transducing adaptor protein-2 (STAP-2) is a recently identified adaptor protein that regulates immune and inflammatory responses through interactions with a variety of signaling and transcriptional molecules. In the current study, we clarified the physiological role of STAP-2 in mast cell function, a key mediator of IgE-associated allergic responses. STAP-2 is constitutively expressed in mast cells. STAP-2 deficiency in mast cells greatly enhances FcRI-mediated signals, resulting in the increased tyrosine phosphorylation of the phospholipase C-g isoform, calcium mobilization, and degranulation. Of importance, STAP-2-deficient mice challenged with DNP-BSA after passive sensitization with anti-DNP IgE show more severe rectal temperature decrease than do wild-type mice. STAP-2-deficient mice also show increased vascular permeability and more severe cutaneous anaphylaxis after DNP-BSA injection. These regulatory functions performed by STAP-2 indicate that there is an interaction between STAP-2 and FcRI. In addition, our previous data indicate that STAP-2 binds to the phospholipase C-g isoform and IkB kinase-b. Therefore, our data described in this article strongly suggest that manipulation of STAP-2 expression in mast cells may control the pathogenesis of allergic diseases and have the potential for treating patients with allergy.
UR - http://www.scopus.com/inward/record.url?scp=84898670990&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84898670990&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1300886
DO - 10.4049/jimmunol.1300886
M3 - Article
C2 - 24616480
AN - SCOPUS:84898670990
SN - 0022-1767
VL - 192
SP - 3488
EP - 3495
JO - Journal of Immunology
JF - Journal of Immunology
IS - 8
ER -